Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement - PubMed (original) (raw)

Review

. 2021 Nov 23;15(11):16982-17015.

doi: 10.1021/acsnano.1c04996. Epub 2021 Jun 28.

Affiliations

• PMID: 34181394
• DOI: 10.1021/acsnano.1c04996

Free article

Review

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Rumiana Tenchov et al. ACS Nano. 2021.

Free article

Abstract

Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of the COVID-19 mRNA vaccines, LNPs play a key role in effectively protecting and transporting mRNA to cells. Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform. A number of liposomal drugs have been approved and applied to medical practice. Subsequent generations of lipid nanocarriers, such as solid lipid nanoparticles, nanostructured lipid carriers, and cationic lipid-nucleic acid complexes, exhibit more complex architectures and enhanced physical stabilities. With their ability to encapsulate and deliver therapeutics to specific locations within the body and to release their contents at a desired time, LNPs provide a valuable platform for treatment of a variety of diseases. Here, we present a landscape of LNP-related scientific publications, including patents and journal articles, based on analysis of the CAS Content Collection, the largest human-curated collection of published scientific knowledge. Rising trends are identified, such as nanostructured lipid carriers and solid lipid nanoparticles becoming the preferred platforms for numerous formulations. Recent advancements in LNP formulations as drug delivery platforms, such as antitumor and nucleic acid therapeutics and vaccine delivery systems, are discussed. Challenges and growth opportunities are also evaluated in other areas, such as medical imaging, cosmetics, nutrition, and agrochemicals. This report is intended to serve as a useful resource for those interested in LNP nanotechnologies, their applications, and the global research effort for their development.

Keywords: cationic lipid; drug delivery; immunoliposome; lipid nanoparticle; liposome; nanostructured lipid carrier; solid lipid nanoparticle; “stealth” liposome.

PubMed Disclaimer

Similar articles

• Chemistry of Lipid Nanoparticles for RNA Delivery.
  Eygeris Y, Gupta M, Kim J, Sahay G. Eygeris Y, et al. Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1. Acc Chem Res. 2022. PMID: 34850635 Review.
• A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs.
  Bogaert B, Sauvage F, Guagliardo R, Muntean C, Nguyen VP, Pottie E, Wels M, Minnaert AK, De Rycke R, Yang Q, Peer D, Sanders N, Remaut K, Paulus YM, Stove C, De Smedt SC, Raemdonck K. Bogaert B, et al. J Control Release. 2022 Oct;350:256-270. doi: 10.1016/j.jconrel.2022.08.009. Epub 2022 Aug 24. J Control Release. 2022. PMID: 35963467 Free PMC article.
• The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
  Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. Hald Albertsen C, et al. Adv Drug Deliv Rev. 2022 Sep;188:114416. doi: 10.1016/j.addr.2022.114416. Epub 2022 Jul 3. Adv Drug Deliv Rev. 2022. PMID: 35787388 Free PMC article. Review.
• Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
  Wang C, Zhang Y, Dong Y. Wang C, et al. Acc Chem Res. 2021 Dec 7;54(23):4283-4293. doi: 10.1021/acs.accounts.1c00550. Epub 2021 Nov 18. Acc Chem Res. 2021. PMID: 34793124 Free PMC article.
• Payload distribution and capacity of mRNA lipid nanoparticles.
  Li S, Hu Y, Li A, Lin J, Hsieh K, Schneiderman Z, Zhang P, Zhu Y, Qiu C, Kokkoli E, Wang TH, Mao HQ. Li S, et al. Nat Commun. 2022 Sep 23;13(1):5561. doi: 10.1038/s41467-022-33157-4. Nat Commun. 2022. PMID: 36151112 Free PMC article.

Cited by

• Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent.
  Ali M, Benfante V, Di Raimondo D, Salvaggio G, Tuttolomondo A, Comelli A. Ali M, et al. Pharmaceuticals (Basel). 2024 Jan 18;17(1):126. doi: 10.3390/ph17010126. Pharmaceuticals (Basel). 2024. PMID: 38256959 Free PMC article. Review.
• Light-Responsive Molecular Release from Cubosomes Using Swell-Squeeze Lattice Control.
  Jones BE, Kelly EA, Cowieson N, Divitini G, Evans RC. Jones BE, et al. J Am Chem Soc. 2022 Oct 26;144(42):19532-19541. doi: 10.1021/jacs.2c08583. Epub 2022 Oct 12. J Am Chem Soc. 2022. PMID: 36222426 Free PMC article.
• Innovations in monoclonal antibody-based multipurpose prevention technology (MPT) for the prevention of sexually transmitted infections and unintended pregnancy.
  Dohadwala S, Geib MT, Politch JA, Anderson DJ. Dohadwala S, et al. Front Reprod Health. 2024 Jan 9;5:1337479. doi: 10.3389/frph.2023.1337479. eCollection 2023. Front Reprod Health. 2024. PMID: 38264184 Free PMC article. Review.
• Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.
  Qiu C, Zhang JZ, Wu B, Xu CC, Pang HH, Tu QC, Lu YQ, Guo QY, Xia F, Wang JG. Qiu C, et al. J Nanobiotechnology. 2023 Nov 29;21(1):456. doi: 10.1186/s12951-023-02165-x. J Nanobiotechnology. 2023. PMID: 38017573 Free PMC article. Review.
• Tailoring biomaterials for vaccine delivery.
  Zhuo Y, Zeng H, Su C, Lv Q, Cheng T, Lei L. Zhuo Y, et al. J Nanobiotechnology. 2024 Aug 12;22(1):480. doi: 10.1186/s12951-024-02758-0. J Nanobiotechnology. 2024. PMID: 39135073 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Chemical Society

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information